Who are Enveda Biosciences's decision-makers?
Enveda Biosciences is led by Viswa Colluru, Founder and CEO, with a leadership bench spanning product, science, operations, and commercialization.
- CEO
- Viswa Colluru
- Key exec
- Daphne Koller
- Founded
- 2019
- Employees
- Private; U.S. and India R&D teams
- HQ
- Boulder, Colorado
- Notable
- Founded Enveda to industrialize natural-product drug discovery.
- Viswa ColluruFounder and CEOFounder · since 2019Founded Enveda to industrialize natural-product drug discovery.
- Daphne KollerBoard/investorBoardAI drug discovery leader and investor involved in company governance.
- Kinnevik / FPV representativesInvestorsInvestorsGrowth investors supporting platform and pipeline scale.
Who leads Enveda Biosciences?
Viswa Colluru serves as Founder and CEO; Daphne Koller serves as Board/investor; Kinnevik / FPV representatives serves as Investors. The leadership pattern reflects the company's focus on ai drug discovery.
For outreach, leadership background matters because it shows whether decisions are likely to be product-led, science-led, clinical, industrial, or government-procurement heavy.
Who actually makes buying decisions at Enveda Biosciences?
Likely buying committees include the executive owner of PRISM platform, security and compliance leaders, finance/procurement, and the technical leaders responsible for integration.
A seller should avoid starting with a generic CEO pitch unless the offer is strategic. Most practical deals will need a functional champion who owns deployment pain and a finance or operations approver.
How is Enveda Biosciences organized as it scales?
Enveda Biosciences's public footprint suggests a scaling private company with cross-functional teams around product, engineering, customer deployment, and go-to-market or R&D. Exact reporting lines are not public.
The safest assumption is a matrixed buying process: technical validation first, operational proof second, and executive approval for larger commitments.
As of June 2026.Sources:Enveda websiteEnveda news
Enveda Biosciences — frequently asked questions
